In contrast, the phosphorylation of both Smad2 and Smad4 was significantly reduced in the tumors treated with the inhibitor (OVA + tumor + Inh), indicating that blocking TβRI inhibits the TGF-β signaling cascade. This evidence concerns the gene SMAD2 and neoplasm.